The DRIVE Project aims at developing a governance model between public and private entities to enable a sustainable network of influenza vaccine effectiveness (IVE). Influenza is a major public health issue, it is thought to infect over 50 million of EU citizens. Vaccines are the cornerstone of preventing influenza, but their effectiveness can vary from year to year and across recipient groups. DRIVE will set up a platform, bringing together all stakeholders, to explore brand-specific effectiveness estimates for all influenza vaccines used in the EU each season, that will ultimately have a positive impact on European citizens public health.

Starting from influenza season 2018/19, organizations with interest and expertise/capacity to perform IVE studies may join the DRIVE network through call for tenders. The purpose of this tender is to extend the DRIVE network by including new study sites capable of producing IVE estimates. Benefits include funding, capacity building & participation in a robust European research network. The call is open to any European organization, institution or network and closes on June 10th 2018.

The DRIVE project, managed by Synapse, started on July 2017 and it`s sponsored by the European Commission and the European pharmaceutical industry (via EFPIA) under the auspices of the Innovative Medicines Initiative Joint Undertaking (IMI JU).

To learn more about the DRIVE project and how to apply for tender click here.